UNSPSC 51284701: Xibornol

This classification denotes a bornane and alcohol with the molecular formula C18H26O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier RQ12GMY0FZ, chemically known as 3,4-xylenol, 6-isobornyl- (8ci) but generally known as xibornol, which bears US NIH Compound Identifier 72144. European Medicines Agency schedules Xibornol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00111MIG. World Health Organization schedules xibornol in its Anatomical Therapeutic Chemical (ATC) Classification.

XIBORNOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule xibornol under HS 29071990 and SITC 51243. As of Q4 2014, XIBORNOL remains the US FDA Preferred Term for this commodity. SMILES: OC1C(C2C3(C(C(C2)CC3)(C)C)C)CC(C(C1)C)C.

UNSPSC 51284701 Xibornol, a Commodity code, does not align with recent state and local procurement activity posted under this classification. The source contains four recent opportunities — a Seminole County, Florida IFB for naloxone and drug deactivation systems; a Texas Health and Human Services Commission RFI on direct-to-manufacturer prescription programs; a City of Tampa IFB for medical and first aid supplies for the Fire Department; and a Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) RFP for generic pharmaceuticals and OTC products — none of which reference xibornol or products matching its nominal scope. The opportunities instead center on naloxone procurement, prescription fulfillment infrastructure, emergency medical supplies, and generic pharmaceutical distribution. State and local buyers issuing under this code include county health departments, state HHS agencies, municipal fire departments, and multistate cooperative purchasing organizations, but no recent activity specifically targets xibornol products.

No state and local contract opportunities in the source material demonstrate current procurement demand for xibornol as a commodity. The code shows minimal relevant recent activity; the mismatch between the code's nominal scope and the actual opportunities posted suggests either misclassification in the source data or dormant procurement activity for this specific product line. Business development activity under this code should be informed by direct outreach to health departments, emergency services procurement offices, and poison control or overdose-response programs to verify whether xibornol demand exists in state and local markets before committing resources to bid infrastructure.